To assess risk factors and associated outcomes with persistent fetal growth restriction (FGR) after mid-trimester diagnosis. Retrospective study of fetuses with FGR by estimated weight (EFW) < 10th percentile or abdominal circumference (AC) < 10th percentile identified between 18 – 24 weeks of gestation without structural or chromosomal anomalies. We compared pregnancies that had persistent FGR (at last scan prior to delivery) to those with resolved FGR. Primary outcome was small for gestational age (SGA) defined as birthweight < 10th percentile by WHO criteria. Secondary outcomes were preterm delivery < 37 weeks of gestation, stillbirth/neonatal death, and maternal outcomes. 398 singleton gestations were diagnosed with FGR between 18.0 – 24.0 weeks of gestation. After exclusion criteria, 161 patients (50.5%) were included for analysis; 69 (42.9%) had resolved FGR and 92 (57.1%) were persistent FGR. Maternal characteristics were similar between groups. Gestational age at diagnostic ultrasound were similar between groups (21 ± 1.4 weeks' gestation vs. 21 ± 1.4 weeks' gestation, p = 0.9). As compared to resolved FGR, pregnancies with persistent FGR were more likely to have: EFW ≤ 3% at initial diagnosis (62% persistent FGR vs. 26.1 resolved FGR%, p < 0.0001), have a trend towards abnormal Doppler studies (27% vs. 15.4% p = 0.17), more likely to be SGA at delivery (72.5% vs. 23.2%; p < 0.001), higher frequency of stillbirth/neonatal death (16.3% vs. 1.5%; p = .001), delivery prior 37 weeks of gestation (46.7% vs. 5.8% p < 0.0001), higher prevalence of maternal hypertensive disorders of pregnancy (41.3% vs. 20.2%; p = 0.006), and prolonged maternal hospital stay following delivery (3.6 ± 3.0 days vs. 2.5 ± 1.1 days; p = 0.004). Fetuses diagnosed with FGR at 18-24 weeks having an EFW ≤ 3rd percentile were likely to have persistent FGR. Those pregnancies for whom FGR persisted were more likely to be SGA at birth and have a higher frequency of fetal demise.
To evaluate the fetal cardiac function as measured by the modified myocardial performance index (Mod-MPI), in twin-to twin transfusion syndrome (TTS) before and after laser surgery. Mod-MPI was measured in the left cardiac chambers of donors and recipients from 20 pregnancies affected with TTS one day before and 3–6 days after laser surgery. The isovolumetric contraction (ICT), relaxation (IRT) and ejection (ET) times were measured using the Doppler signals of the aperture and closure (clicks) of the mitral and aortic valves as landmarks. Mod-MPI was calculated as IVT + IVT/ET and a value above 0.42 (P95) was considered abnormal. Before laser, recipients had a Mod-MPI of (Mean, SD) 0.48 (0.11) and donors of 0.36 (0.06) and (p = 0.0001). Three donors had a Mod-MPI above 0.42. After laser, the recipients decreased the Mod-MPI to 0.41 (0.05) (versus pre-treatment values p = 0.0001), whereas in donors it increased to 0.39 (0.06) (p = 0.007), and the differences between recipient and donor observed before laser became non-significant. Of the 3 donors with increased Mod-MPI before therapy, two died afterwards. Alterations in the Mod-MPI reflect the hemodynamic disturbances of TTS and its modification after laser therapy. An increased Mod-MPI before treatment in the donor might further indicate a poor prognosis after laser, but this observation must be confirmed in larger studies.
To assess the learning curve for the fetal lung area to head circumference ratio (LHR) calculation in fetuses with congenital diaphragmatic hernia (CDH).Three trainees with the theoretical knowledge, but without prior experience in the LHR measurement, were selected. Each trainee and one experienced examiner measured the observed to expected (O/E)-LHR in the lung contralateral to the side of the hernia by two methods-manual tracing of lung borders and multiplication of the longest diameters-in a cohort of 95 consecutive CDH fetuses. The average difference between the three trainees and the expert in the O/E-LHR measurement was calculated. A difference below 10% was considered to indicate an accurate measurement. The average learning curve was delineated using cumulative sum analysis (CUSUM).The CUSUM plots demonstrate that the learning curve was achieved by 77 and 72 tests performed for the area obtained by the manual-tracing and multiplication-of-the-longest-diameter methods, respectively.The minimum number of scans required for an inexperienced trainee to become competent in examining the LHR is on average 70.
To evaluate lung tissue perfusion in fetuses with congenital diaphragmatic hernia (CDH) and to explore the association of lung tissue perfusion with the lung area to head circumference ratio (LHR) and intrapulmonary artery pulsed Doppler.Fetuses with isolated left CDH were evaluated and compared with a group of fetuses without CDH, which were sampled from our general population and matched by gestational age at inclusion. Lung tissue perfusion measured using fractional moving blood volume (FMBV), the observed to expected (O/E) LHR and pulsed Doppler of the proximal intrapulmonary artery were evaluated in the lung contralateral to the side of the hernia. Doppler waveform analysis included the pulsatility index (PI), the peak early diastolic reversed flow (PEDRF) and the peak systolic velocity (PSV). All Doppler parameters were converted into Z-scores for gestational age. The associations between FMBV and O/E-LHR and between FMBV and intrapulmonary arterial Doppler parameters were analyzed using multiple linear regression, adjusted by gestational age.A total of 190 fetuses (95 with CDH and 95 controls) were evaluated. Fetuses with CDH showed significantly lower lung FMBV (26.8 (SD 8.4) vs. 37.9 (SD 8.1)%; P < 0.001) than controls. Lung tissue perfusion correlated positively with O/E-LHR (r = 0.37; P < 0.001) and negatively with intrapulmonary artery PI (r = - 0.31; P < 0.001), PEDRF (r = - 0.43; P < 0.001) and PSV (r = - 0.18; P = 0.03).Fetuses with CDH have decreased lung tissue perfusion, which is associated with decreased lung growth and increased intrapulmonary artery impedance.
To develop a standardized method for quantification of the power Doppler signals recorded from fetal organs, compensating for factors (instrument settings, depth, and attenuation) that can affect the results. The method by Rubin et al. has been modified and fractional moving blood volume (FMBV) was estimated within the standardized region of interest within the fetal lung The method was evaluated in an in vitro model and then applied in an animal experimental model. In fetal sheep, the measurements of FMBV were compared with blood perfusion measurements using radioactive labeled microspheres. A test of the reproducibility of the FMBV estimation was performed by two independent operators in the lungs of 20 human fetuses. Then the method was applied on a clinical material. FMBV was estimated in the lung of 47 normally grown and 25 growth restricted (IUGR) fetuses after 32 weeks of gestation. 1) A high correlation was found between the FMBV and radioactive labeled microspheres in measurement of fetal adrenal gland perfusion (r = 0.90). 2) The reproducibility test gave satisfactory results: Intraclass correlation coefficient 0.92 (95% confidence interval [CI] 0.78–0.96); interclass correlation coefficient 0.70 (95%CI 0.56–0.76), Kappa index 0.82 (95%CI 0.51–0.93). 3) The normal fetuses showed a higher lung FMBV values than the IUGR fetuses (P = 0.003). There was no association between the FMBV and respiratory complications during neonatal period. The power Doppler FMBV method proved to give an estimate of fetal organ blood perfusion. A standardized and reproducible method of examining fetal lung circulation has been developed. The clinical potential of the power Doppler FMBV method, e.g., for prediction of lung hypoplasia, remains to be established.